New blood test could replace risky biopsies for liver transplant patients
NCT ID NCT06153641
Summary
This study aims to develop a simple blood test to detect when a patient's body is rejecting a transplanted liver. Currently, doctors must perform a risky liver biopsy to diagnose rejection. Researchers will measure a protein called CK-18 in the blood of transplant patients and healthy volunteers to see if it reliably signals rejection without needing an invasive procedure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER TRANSPLANT FAILURE AND REJECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
SSM Health Cardinal Glennon Children's Hospital & Saint Louis University Hospital (SSM Health- SLU Hospital)
St Louis, Missouri, 63104, United States
Conditions
Explore the condition pages connected to this study.